Natalizumab Treatment of Progressive Multiple Sclerosis (NAPMS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01077466
Recruitment Status : Completed
First Posted : March 1, 2010
Last Update Posted : February 17, 2012
Copenhagen University Hospital, Hvidovre
University of Copenhagen
Signifikans ApS
Information provided by (Responsible Party):
Finn Sellebjerg, Rigshospitalet, Denmark

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2012
  Actual Study Completion Date : January 2012